IGC Pharma, Inc. (IGC) vs Kyntra Bio Inc (KYNB)
IGC Pharma, Inc. and Kyntra Bio Inc are both Biotechnology companies. IGC Pharma, Inc. and Kyntra Bio Inc are of similar size ($29.1M and $28.3M). IGC Pharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Kyntra Bio Inc trades at 0.2×. IGC Pharma, Inc. grew revenue faster over the last twelve months: −13.4% against −37.2%. Kyntra Bio Inc has the higher net margin (3,967.8% vs −795.5%) and the higher return on invested capital (0.00% vs −91.5%). Across the 17 metrics below, Kyntra Bio Inc leads on 9 and IGC Pharma, Inc. on 8.
Valuation
Profitability
| Metric | IGC | KYNB | Biotechnology median |
|---|---|---|---|
| Gross margin | 32.33% | 6.28% | 65.16% |
| Operating margin | (912.44%) | (1,089.78%) | 0.00% |
| Net margin | (795.46%) | 3,967.77% | 0.00% |
| Free cash flow margin | (516.53%) | (824.19%) | 0.00% |
| Return on equity | (143.46%) | (157.83%) | (57.72%) |
| Return on assets | (100.44%) | 131.26% | (49.22%) |
| Return on invested capital | (91.53%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack